img

Global Active Pharmaceutical Ingredient Excipient Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Active Pharmaceutical Ingredient Excipient Market Insights, Forecast to 2034

The global Active Pharmaceutical Ingredient Excipient market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Active Pharmaceutical Ingredient Excipient is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Active Pharmaceutical Ingredient Excipient is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Active Pharmaceutical Ingredient Excipient is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Active Pharmaceutical Ingredient Excipient include BASF, Ashland, Roquette Freres, Colorcon, Croda Health Care, Dow and DuPont, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Active Pharmaceutical Ingredient Excipient, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Active Pharmaceutical Ingredient Excipient, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Active Pharmaceutical Ingredient Excipient, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Active Pharmaceutical Ingredient Excipient sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Active Pharmaceutical Ingredient Excipient market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Active Pharmaceutical Ingredient Excipient sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BASF, Ashland, Roquette Freres, Colorcon, Croda Health Care, Dow and DuPont, etc.



By Company


BASF
Ashland
Roquette Freres
Colorcon
Croda Health Care
Dow
DuPont
Segment by Type
Synthetic Chemical APIs
Natural Chemical APIs

Segment by Application


Oral Formulations
Topical Formulations
Parenteral Formulations
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Active Pharmaceutical Ingredient Excipient in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Active Pharmaceutical Ingredient Excipient manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Active Pharmaceutical Ingredient Excipient sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Active Pharmaceutical Ingredient Excipient Product Introduction
1.2 Market by Type
1.2.1 Global Active Pharmaceutical Ingredient Excipient Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Synthetic Chemical APIs
1.2.3 Natural Chemical APIs
1.3 Market by Application
1.3.1 Global Active Pharmaceutical Ingredient Excipient Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Oral Formulations
1.3.3 Topical Formulations
1.3.4 Parenteral Formulations
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Active Pharmaceutical Ingredient Excipient Sales Estimates and Forecasts 2018-2034
2.2 Global Active Pharmaceutical Ingredient Excipient Revenue by Region
2.2.1 Global Active Pharmaceutical Ingredient Excipient Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Active Pharmaceutical Ingredient Excipient Revenue by Region (2018-2024)
2.2.3 Global Active Pharmaceutical Ingredient Excipient Revenue by Region (2024-2034)
2.2.4 Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Region (2018-2034)
2.3 Global Active Pharmaceutical Ingredient Excipient Sales Estimates and Forecasts 2018-2034
2.4 Global Active Pharmaceutical Ingredient Excipient Sales by Region
2.4.1 Global Active Pharmaceutical Ingredient Excipient Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Active Pharmaceutical Ingredient Excipient Sales by Region (2018-2024)
2.4.3 Global Active Pharmaceutical Ingredient Excipient Sales by Region (2024-2034)
2.4.4 Global Active Pharmaceutical Ingredient Excipient Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Active Pharmaceutical Ingredient Excipient Sales by Manufacturers
3.1.1 Global Active Pharmaceutical Ingredient Excipient Sales by Manufacturers (2018-2024)
3.1.2 Global Active Pharmaceutical Ingredient Excipient Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Active Pharmaceutical Ingredient Excipient in 2022
3.2 Global Active Pharmaceutical Ingredient Excipient Revenue by Manufacturers
3.2.1 Global Active Pharmaceutical Ingredient Excipient Revenue by Manufacturers (2018-2024)
3.2.2 Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredient Excipient Revenue in 2022
3.3 Global Key Players of Active Pharmaceutical Ingredient Excipient, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Active Pharmaceutical Ingredient Excipient Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Active Pharmaceutical Ingredient Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Active Pharmaceutical Ingredient Excipient, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Active Pharmaceutical Ingredient Excipient, Product Offered and Application
3.8 Global Key Manufacturers of Active Pharmaceutical Ingredient Excipient, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Active Pharmaceutical Ingredient Excipient Sales by Type
4.1.1 Global Active Pharmaceutical Ingredient Excipient Historical Sales by Type (2018-2024)
4.1.2 Global Active Pharmaceutical Ingredient Excipient Forecasted Sales by Type (2024-2034)
4.1.3 Global Active Pharmaceutical Ingredient Excipient Sales Market Share by Type (2018-2034)
4.2 Global Active Pharmaceutical Ingredient Excipient Revenue by Type
4.2.1 Global Active Pharmaceutical Ingredient Excipient Historical Revenue by Type (2018-2024)
4.2.2 Global Active Pharmaceutical Ingredient Excipient Forecasted Revenue by Type (2024-2034)
4.2.3 Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Type (2018-2034)
4.3 Global Active Pharmaceutical Ingredient Excipient Price by Type
4.3.1 Global Active Pharmaceutical Ingredient Excipient Price by Type (2018-2024)
4.3.2 Global Active Pharmaceutical Ingredient Excipient Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Active Pharmaceutical Ingredient Excipient Sales by Application
5.1.1 Global Active Pharmaceutical Ingredient Excipient Historical Sales by Application (2018-2024)
5.1.2 Global Active Pharmaceutical Ingredient Excipient Forecasted Sales by Application (2024-2034)
5.1.3 Global Active Pharmaceutical Ingredient Excipient Sales Market Share by Application (2018-2034)
5.2 Global Active Pharmaceutical Ingredient Excipient Revenue by Application
5.2.1 Global Active Pharmaceutical Ingredient Excipient Historical Revenue by Application (2018-2024)
5.2.2 Global Active Pharmaceutical Ingredient Excipient Forecasted Revenue by Application (2024-2034)
5.2.3 Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Application (2018-2034)
5.3 Global Active Pharmaceutical Ingredient Excipient Price by Application
5.3.1 Global Active Pharmaceutical Ingredient Excipient Price by Application (2018-2024)
5.3.2 Global Active Pharmaceutical Ingredient Excipient Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Active Pharmaceutical Ingredient Excipient Market Size by Type
6.1.1 US & Canada Active Pharmaceutical Ingredient Excipient Sales by Type (2018-2034)
6.1.2 US & Canada Active Pharmaceutical Ingredient Excipient Revenue by Type (2018-2034)
6.2 US & Canada Active Pharmaceutical Ingredient Excipient Market Size by Application
6.2.1 US & Canada Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2034)
6.2.2 US & Canada Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2034)
6.3 US & Canada Active Pharmaceutical Ingredient Excipient Market Size by Country
6.3.1 US & Canada Active Pharmaceutical Ingredient Excipient Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Active Pharmaceutical Ingredient Excipient Sales by Country (2018-2034)
6.3.3 US & Canada Active Pharmaceutical Ingredient Excipient Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Active Pharmaceutical Ingredient Excipient Market Size by Type
7.1.1 Europe Active Pharmaceutical Ingredient Excipient Sales by Type (2018-2034)
7.1.2 Europe Active Pharmaceutical Ingredient Excipient Revenue by Type (2018-2034)
7.2 Europe Active Pharmaceutical Ingredient Excipient Market Size by Application
7.2.1 Europe Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2034)
7.2.2 Europe Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2034)
7.3 Europe Active Pharmaceutical Ingredient Excipient Market Size by Country
7.3.1 Europe Active Pharmaceutical Ingredient Excipient Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Active Pharmaceutical Ingredient Excipient Sales by Country (2018-2034)
7.3.3 Europe Active Pharmaceutical Ingredient Excipient Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Active Pharmaceutical Ingredient Excipient Market Size
8.1.1 China Active Pharmaceutical Ingredient Excipient Sales (2018-2034)
8.1.2 China Active Pharmaceutical Ingredient Excipient Revenue (2018-2034)
8.2 China Active Pharmaceutical Ingredient Excipient Market Size by Application
8.2.1 China Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2034)
8.2.2 China Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Active Pharmaceutical Ingredient Excipient Market Size by Type
9.1.1 Asia Active Pharmaceutical Ingredient Excipient Sales by Type (2018-2034)
9.1.2 Asia Active Pharmaceutical Ingredient Excipient Revenue by Type (2018-2034)
9.2 Asia Active Pharmaceutical Ingredient Excipient Market Size by Application
9.2.1 Asia Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2034)
9.2.2 Asia Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2034)
9.3 Asia Active Pharmaceutical Ingredient Excipient Sales by Region
9.3.1 Asia Active Pharmaceutical Ingredient Excipient Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Active Pharmaceutical Ingredient Excipient Revenue by Region (2018-2034)
9.3.3 Asia Active Pharmaceutical Ingredient Excipient Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Market Size by Type
10.1.1 Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Market Size by Application
10.2.1 Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales by Country
10.3.1 Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 BASF
11.1.1 BASF Company Information
11.1.2 BASF Overview
11.1.3 BASF Active Pharmaceutical Ingredient Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 BASF Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BASF Recent Developments
11.2 Ashland
11.2.1 Ashland Company Information
11.2.2 Ashland Overview
11.2.3 Ashland Active Pharmaceutical Ingredient Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Ashland Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ashland Recent Developments
11.3 Roquette Freres
11.3.1 Roquette Freres Company Information
11.3.2 Roquette Freres Overview
11.3.3 Roquette Freres Active Pharmaceutical Ingredient Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Roquette Freres Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roquette Freres Recent Developments
11.4 Colorcon
11.4.1 Colorcon Company Information
11.4.2 Colorcon Overview
11.4.3 Colorcon Active Pharmaceutical Ingredient Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Colorcon Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Colorcon Recent Developments
11.5 Croda Health Care
11.5.1 Croda Health Care Company Information
11.5.2 Croda Health Care Overview
11.5.3 Croda Health Care Active Pharmaceutical Ingredient Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Croda Health Care Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Croda Health Care Recent Developments
11.6 Dow
11.6.1 Dow Company Information
11.6.2 Dow Overview
11.6.3 Dow Active Pharmaceutical Ingredient Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Dow Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dow Recent Developments
11.7 DuPont
11.7.1 DuPont Company Information
11.7.2 DuPont Overview
11.7.3 DuPont Active Pharmaceutical Ingredient Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 DuPont Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 DuPont Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Active Pharmaceutical Ingredient Excipient Industry Chain Analysis
12.2 Active Pharmaceutical Ingredient Excipient Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Active Pharmaceutical Ingredient Excipient Production Mode & Process
12.4 Active Pharmaceutical Ingredient Excipient Sales and Marketing
12.4.1 Active Pharmaceutical Ingredient Excipient Sales Channels
12.4.2 Active Pharmaceutical Ingredient Excipient Distributors
12.5 Active Pharmaceutical Ingredient Excipient Customers
13 Market Dynamics
13.1 Active Pharmaceutical Ingredient Excipient Industry Trends
13.2 Active Pharmaceutical Ingredient Excipient Market Drivers
13.3 Active Pharmaceutical Ingredient Excipient Market Challenges
13.4 Active Pharmaceutical Ingredient Excipient Market Restraints
14 Key Findings in The Global Active Pharmaceutical Ingredient Excipient Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Active Pharmaceutical Ingredient Excipient Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Synthetic Chemical APIs
Table 3. Major Manufacturers of Natural Chemical APIs
Table 4. Global Active Pharmaceutical Ingredient Excipient Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Active Pharmaceutical Ingredient Excipient Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Active Pharmaceutical Ingredient Excipient Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Active Pharmaceutical Ingredient Excipient Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Region (2018-2024)
Table 9. Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Region (2024-2034)
Table 10. Global Active Pharmaceutical Ingredient Excipient Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Active Pharmaceutical Ingredient Excipient Sales by Region (2018-2024) & (Kg)
Table 12. Global Active Pharmaceutical Ingredient Excipient Sales by Region (2024-2034) & (Kg)
Table 13. Global Active Pharmaceutical Ingredient Excipient Sales Market Share by Region (2018-2024)
Table 14. Global Active Pharmaceutical Ingredient Excipient Sales Market Share by Region (2024-2034)
Table 15. Global Active Pharmaceutical Ingredient Excipient Sales by Manufacturers (2018-2024) & (Kg)
Table 16. Global Active Pharmaceutical Ingredient Excipient Sales Share by Manufacturers (2018-2024)
Table 17. Global Active Pharmaceutical Ingredient Excipient Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Active Pharmaceutical Ingredient Excipient Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Active Pharmaceutical Ingredient Excipient, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Active Pharmaceutical Ingredient Excipient Price by Manufacturers 2018-2024 (US$/Kg)
Table 21. Global Active Pharmaceutical Ingredient Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Active Pharmaceutical Ingredient Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredient Excipient as of 2022)
Table 23. Global Key Manufacturers of Active Pharmaceutical Ingredient Excipient, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Active Pharmaceutical Ingredient Excipient, Product Offered and Application
Table 25. Global Key Manufacturers of Active Pharmaceutical Ingredient Excipient, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Active Pharmaceutical Ingredient Excipient Sales by Type (2018-2024) & (Kg)
Table 28. Global Active Pharmaceutical Ingredient Excipient Sales by Type (2024-2034) & (Kg)
Table 29. Global Active Pharmaceutical Ingredient Excipient Sales Share by Type (2018-2024)
Table 30. Global Active Pharmaceutical Ingredient Excipient Sales Share by Type (2024-2034)
Table 31. Global Active Pharmaceutical Ingredient Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Active Pharmaceutical Ingredient Excipient Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Active Pharmaceutical Ingredient Excipient Revenue Share by Type (2018-2024)
Table 34. Global Active Pharmaceutical Ingredient Excipient Revenue Share by Type (2024-2034)
Table 35. Active Pharmaceutical Ingredient Excipient Price by Type (2018-2024) & (US$/Kg)
Table 36. Global Active Pharmaceutical Ingredient Excipient Price Forecast by Type (2024-2034) & (US$/Kg)
Table 37. Global Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2024) & (Kg)
Table 38. Global Active Pharmaceutical Ingredient Excipient Sales by Application (2024-2034) & (Kg)
Table 39. Global Active Pharmaceutical Ingredient Excipient Sales Share by Application (2018-2024)
Table 40. Global Active Pharmaceutical Ingredient Excipient Sales Share by Application (2024-2034)
Table 41. Global Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Active Pharmaceutical Ingredient Excipient Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Active Pharmaceutical Ingredient Excipient Revenue Share by Application (2018-2024)
Table 44. Global Active Pharmaceutical Ingredient Excipient Revenue Share by Application (2024-2034)
Table 45. Active Pharmaceutical Ingredient Excipient Price by Application (2018-2024) & (US$/Kg)
Table 46. Global Active Pharmaceutical Ingredient Excipient Price Forecast by Application (2024-2034) & (US$/Kg)
Table 47. US & Canada Active Pharmaceutical Ingredient Excipient Sales by Type (2018-2024) & (Kg)
Table 48. US & Canada Active Pharmaceutical Ingredient Excipient Sales by Type (2024-2034) & (Kg)
Table 49. US & Canada Active Pharmaceutical Ingredient Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Active Pharmaceutical Ingredient Excipient Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2024) & (Kg)
Table 52. US & Canada Active Pharmaceutical Ingredient Excipient Sales by Application (2024-2034) & (Kg)
Table 53. US & Canada Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Active Pharmaceutical Ingredient Excipient Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Active Pharmaceutical Ingredient Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada Active Pharmaceutical Ingredient Excipient Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Active Pharmaceutical Ingredient Excipient Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Active Pharmaceutical Ingredient Excipient Sales by Country (2018-2024) & (Kg)
Table 59. US & Canada Active Pharmaceutical Ingredient Excipient Sales by Country (2024-2034) & (Kg)
Table 60. Europe Active Pharmaceutical Ingredient Excipient Sales by Type (2018-2024) & (Kg)
Table 61. Europe Active Pharmaceutical Ingredient Excipient Sales by Type (2024-2034) & (Kg)
Table 62. Europe Active Pharmaceutical Ingredient Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Active Pharmaceutical Ingredient Excipient Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2024) & (Kg)
Table 65. Europe Active Pharmaceutical Ingredient Excipient Sales by Application (2024-2034) & (Kg)
Table 66. Europe Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Active Pharmaceutical Ingredient Excipient Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Active Pharmaceutical Ingredient Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 69. Europe Active Pharmaceutical Ingredient Excipient Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Active Pharmaceutical Ingredient Excipient Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Active Pharmaceutical Ingredient Excipient Sales by Country (2018-2024) & (Kg)
Table 72. Europe Active Pharmaceutical Ingredient Excipient Sales by Country (2024-2034) & (Kg)
Table 73. China Active Pharmaceutical Ingredient Excipient Sales by Type (2018-2024) & (Kg)
Table 74. China Active Pharmaceutical Ingredient Excipient Sales by Type (2024-2034) & (Kg)
Table 75. China Active Pharmaceutical Ingredient Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Active Pharmaceutical Ingredient Excipient Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2024) & (Kg)
Table 78. China Active Pharmaceutical Ingredient Excipient Sales by Application (2024-2034) & (Kg)
Table 79. China Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Active Pharmaceutical Ingredient Excipient Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Active Pharmaceutical Ingredient Excipient Sales by Type (2018-2024) & (Kg)
Table 82. Asia Active Pharmaceutical Ingredient Excipient Sales by Type (2024-2034) & (Kg)
Table 83. Asia Active Pharmaceutical Ingredient Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Active Pharmaceutical Ingredient Excipient Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2024) & (Kg)
Table 86. Asia Active Pharmaceutical Ingredient Excipient Sales by Application (2024-2034) & (Kg)
Table 87. Asia Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Active Pharmaceutical Ingredient Excipient Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Active Pharmaceutical Ingredient Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 90. Asia Active Pharmaceutical Ingredient Excipient Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Active Pharmaceutical Ingredient Excipient Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Active Pharmaceutical Ingredient Excipient Sales by Region (2018-2024) & (Kg)
Table 93. Asia Active Pharmaceutical Ingredient Excipient Sales by Region (2024-2034) & (Kg)
Table 94. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales by Type (2018-2024) & (Kg)
Table 95. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales by Type (2024-2034) & (Kg)
Table 96. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales by Application (2018-2024) & (Kg)
Table 99. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales by Application (2024-2034) & (Kg)
Table 100. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales by Country (2018-2024) & (Kg)
Table 106. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales by Country (2024-2034) & (Kg)
Table 107. BASF Company Information
Table 108. BASF Description and Major Businesses
Table 109. BASF Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 110. BASF Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. BASF Recent Developments
Table 112. Ashland Company Information
Table 113. Ashland Description and Major Businesses
Table 114. Ashland Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 115. Ashland Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Ashland Recent Developments
Table 117. Roquette Freres Company Information
Table 118. Roquette Freres Description and Major Businesses
Table 119. Roquette Freres Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 120. Roquette Freres Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Roquette Freres Recent Developments
Table 122. Colorcon Company Information
Table 123. Colorcon Description and Major Businesses
Table 124. Colorcon Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 125. Colorcon Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Colorcon Recent Developments
Table 127. Croda Health Care Company Information
Table 128. Croda Health Care Description and Major Businesses
Table 129. Croda Health Care Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 130. Croda Health Care Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Croda Health Care Recent Developments
Table 132. Dow Company Information
Table 133. Dow Description and Major Businesses
Table 134. Dow Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 135. Dow Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Dow Recent Developments
Table 137. DuPont Company Information
Table 138. DuPont Description and Major Businesses
Table 139. DuPont Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 140. DuPont Active Pharmaceutical Ingredient Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. DuPont Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Active Pharmaceutical Ingredient Excipient Distributors List
Table 145. Active Pharmaceutical Ingredient Excipient Customers List
Table 146. Active Pharmaceutical Ingredient Excipient Market Trends
Table 147. Active Pharmaceutical Ingredient Excipient Market Drivers
Table 148. Active Pharmaceutical Ingredient Excipient Market Challenges
Table 149. Active Pharmaceutical Ingredient Excipient Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharmaceutical Ingredient Excipient Product Picture
Figure 2. Global Active Pharmaceutical Ingredient Excipient Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Active Pharmaceutical Ingredient Excipient Market Share by Type in 2022 & 2034
Figure 4. Synthetic Chemical APIs Product Picture
Figure 5. Natural Chemical APIs Product Picture
Figure 6. Global Active Pharmaceutical Ingredient Excipient Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Active Pharmaceutical Ingredient Excipient Market Share by Application in 2022 & 2034
Figure 8. Oral Formulations
Figure 9. Topical Formulations
Figure 10. Parenteral Formulations
Figure 11. Other
Figure 12. Active Pharmaceutical Ingredient Excipient Report Years Considered
Figure 13. Global Active Pharmaceutical Ingredient Excipient Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Active Pharmaceutical Ingredient Excipient Revenue 2018-2034 (US$ Million)
Figure 15. Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Region (2018-2034)
Figure 17. Global Active Pharmaceutical Ingredient Excipient Sales 2018-2034 ((Kg)
Figure 18. Global Active Pharmaceutical Ingredient Excipient Sales Market Share by Region (2018-2034)
Figure 19. US & Canada Active Pharmaceutical Ingredient Excipient Sales YoY (2018-2034) & (Kg)
Figure 20. US & Canada Active Pharmaceutical Ingredient Excipient Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Active Pharmaceutical Ingredient Excipient Sales YoY (2018-2034) & (Kg)
Figure 22. Europe Active Pharmaceutical Ingredient Excipient Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Active Pharmaceutical Ingredient Excipient Sales YoY (2018-2034) & (Kg)
Figure 24. China Active Pharmaceutical Ingredient Excipient Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Asia (excluding China) Active Pharmaceutical Ingredient Excipient Sales YoY (2018-2034) & (Kg)
Figure 26. Asia (excluding China) Active Pharmaceutical Ingredient Excipient Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales YoY (2018-2034) & (Kg)
Figure 28. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Active Pharmaceutical Ingredient Excipient Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Active Pharmaceutical Ingredient Excipient in the World: Market Share by Active Pharmaceutical Ingredient Excipient Revenue in 2022
Figure 31. Global Active Pharmaceutical Ingredient Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Active Pharmaceutical Ingredient Excipient Sales Market Share by Type (2018-2034)
Figure 33. Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Type (2018-2034)
Figure 34. Global Active Pharmaceutical Ingredient Excipient Sales Market Share by Application (2018-2034)
Figure 35. Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Application (2018-2034)
Figure 36. US & Canada Active Pharmaceutical Ingredient Excipient Sales Market Share by Type (2018-2034)
Figure 37. US & Canada Active Pharmaceutical Ingredient Excipient Revenue Market Share by Type (2018-2034)
Figure 38. US & Canada Active Pharmaceutical Ingredient Excipient Sales Market Share by Application (2018-2034)
Figure 39. US & Canada Active Pharmaceutical Ingredient Excipient Revenue Market Share by Application (2018-2034)
Figure 40. US & Canada Active Pharmaceutical Ingredient Excipient Revenue Share by Country (2018-2034)
Figure 41. US & Canada Active Pharmaceutical Ingredient Excipient Sales Share by Country (2018-2034)
Figure 42. U.S. Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Active Pharmaceutical Ingredient Excipient Sales Market Share by Type (2018-2034)
Figure 45. Europe Active Pharmaceutical Ingredient Excipient Revenue Market Share by Type (2018-2034)
Figure 46. Europe Active Pharmaceutical Ingredient Excipient Sales Market Share by Application (2018-2034)
Figure 47. Europe Active Pharmaceutical Ingredient Excipient Revenue Market Share by Application (2018-2034)
Figure 48. Europe Active Pharmaceutical Ingredient Excipient Revenue Share by Country (2018-2034)
Figure 49. Europe Active Pharmaceutical Ingredient Excipient Sales Share by Country (2018-2034)
Figure 50. Germany Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 51. France Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 52. U.K. Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 53. Italy Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 54. Russia Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 55. China Active Pharmaceutical Ingredient Excipient Sales Market Share by Type (2018-2034)
Figure 56. China Active Pharmaceutical Ingredient Excipient Revenue Market Share by Type (2018-2034)
Figure 57. China Active Pharmaceutical Ingredient Excipient Sales Market Share by Application (2018-2034)
Figure 58. China Active Pharmaceutical Ingredient Excipient Revenue Market Share by Application (2018-2034)
Figure 59. Asia Active Pharmaceutical Ingredient Excipient Sales Market Share by Type (2018-2034)
Figure 60. Asia Active Pharmaceutical Ingredient Excipient Revenue Market Share by Type (2018-2034)
Figure 61. Asia Active Pharmaceutical Ingredient Excipient Sales Market Share by Application (2018-2034)
Figure 62. Asia Active Pharmaceutical Ingredient Excipient Revenue Market Share by Application (2018-2034)
Figure 63. Asia Active Pharmaceutical Ingredient Excipient Revenue Share by Region (2018-2034)
Figure 64. Asia Active Pharmaceutical Ingredient Excipient Sales Share by Region (2018-2034)
Figure 65. Japan Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 66. South Korea Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 67. China Taiwan Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 68. Southeast Asia Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 69. India Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue Market Share by Type (2018-2034)
Figure 72. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue Market Share by Application (2018-2034)
Figure 74. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Revenue Share by Country (2018-2034)
Figure 75. Middle East, Africa and Latin America Active Pharmaceutical Ingredient Excipient Sales Share by Country (2018-2034)
Figure 76. Brazil Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 77. Mexico Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 78. Turkey Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 79. Israel Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 80. GCC Countries Active Pharmaceutical Ingredient Excipient Revenue (2018-2034) & (US$ Million)
Figure 81. Active Pharmaceutical Ingredient Excipient Value Chain
Figure 82. Active Pharmaceutical Ingredient Excipient Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries